Lv2
158 积分 2021-04-20 加入
Neoadjuvant chemotherapy with or without anthracyclines in the presence of dual HER2 blockade for HER2-positive breast cancer (TRAIN-2): a multicentre, open-label, randomised, phase 3 trial
12天前
已完结
Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: a randomized phase II cardiac safety study (TRYPHAENA)
13天前
已完结
神经内镜经鼻蝶入路切除颅底脊索瘤的临床疗效及其影响因素分析
1个月前
已完结
颈椎脊索瘤无复发生存率的影响因素及预测模型
2个月前
已完结
颅底脊索瘤原发和局部复发阶段的病理学变化特点及其预后意义
2个月前
已完结
脊索瘤分子标志物和治疗靶点的研究进展
2个月前
已完结
颅底脊索瘤多学科诊疗专家共识
2个月前
已完结
脊索瘤分子调控机制的研究进展
2个月前
已完结
Genetic variation across and within individuals
4个月前
已完结
皖公网安备34019202002308
